Testing effectiveness (Phase 2)Study completedNCT02671461
What this trial is testing
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
Who this might be right for
Thrombosis
Bristol-Myers Squibb 16